Helicobacter species are associated with possible increase in risk of biliary lithiasis and benign biliary diseases.
BACKGROUND
Hepato-biliary tract lithiasis is common and present either as pain or as asymptomatic on abdominal ultrasonography for other causes. Although the DNA of Helicobacter species are identified in the gallbladder bile, tissue or stones analyzed from these cases, still a causal relationship could not be established due to different results from different geographical parts.


METHODS
A detailed search of pubmed and pubmedcentral was carried out with key words Helicobacter and gallbladder, gallstones, hepaticolithiasis, cholelithiasis and choledocholithiasis, benign biliary diseases, liver diseases. The data was entered in a data base and meta analysis was carried out. The analysis was carried out using odds ratio and a fixed effect model, 95% confidence intervals for odds ratio was calculated. Chi square test for heterogeneity was employed. The overall effect was calculated using Z test.


RESULTS
A total of 12 articles were identified. One study used IgG for diagnosis while others used the PCR for Ure A gene, 16 S RNA or Cag A genes. A couple of studies used culture or histopathology besides the PCR. The cumulative results show a higher association of Helicobacter with chronic liver diseases (30.48%), and stone diseases (42.96%)(OR 1.77 95% CI 1.2-2.58; Z = 2.94, p = 0.003), the effect of each could not be identified as it was difficult to isolate the effect of helicobacter due to mixing of cases in each study.


CONCLUSIONS
The results of present meta analysis shows that there is a slight higher risk of cholelithiasis and benign liver disease (OR 1.77), however due to inherent inability to isolate the effect of stone disease from that of other benign lesions it is not possible to say for sure that Helicobacter has a casual relationship with benign biliary disease or stone disease or both.
Pandey
Manoj
M
Department of Surgical Oncology, Institute of Medical Sciences, Banaras Hindu University, Varanasi 221 005, India. manojpandey@vsnl.com.
World J Gastroenterol. 2002 Apr;8(2):301-4
11925612
Dig Dis Sci. 1995 Oct;40(10):2214-9
7587792
J Clin Microbiol. 1996 Dec;34(12):2952-8
8940429
J Clin Microbiol. 1994 May;32(5):1238-45
8051250
Dig Dis Sci. 2000 Jul;45(7):1405-12
10961722
Lancet. 1991 Nov 9;338(8776):1175-6
1682595
Gastroenterology. 2001 Jan;120(1):323-4
11246512
Lancet. 1998 Sep 12;352(9131):878
9742983
Rev Infect Dis. 1990 Jan-Feb;12 Suppl 1:S87-93
2406862
Aliment Pharmacol Ther. 2005 Oct 15;22(8):715-20
16197492
Infect Immun. 2003 Jun;71(6):3667-72
12761159
Kathmandu Univ Med J (KUMJ). 2004 Oct-Dec;2(4):331-5
16388245
J Clin Microbiol. 2003 Dec;41(12):5615-8
14662950
Gastroenterology. 1998 Apr;114(4):755-63
9516396
Gastroenterology. 2005 Apr;128(4):1023-33
15825083
Dig Liver Dis. 2003 Apr;35(4):237-43
12801034
J Pathol. 2001 Feb;193(2):218-23
11180169
BMJ. 1994 Oct 29;309(6962):1119-23
7987103
Epidemiol Infect. 2004 Dec;132(6):1185-9
15635979
J Clin Gastroenterol. 2005 Feb;39(2):134-7
15681909
J Clin Microbiol. 1995 Feb;33(2):445-54
7536217
Lancet. 1984 Jun 16;1(8390):1311-5
6145023
Jpn J Cancer Res. 2002 Jul;93(7):842-7
12149151
Dig Liver Dis. 2006 Mar;38(3):171-6
16464652
J Natl Cancer Inst. 1991 May 1;83(9):640-3
2023282
Br Heart J. 1994 May;71(5):437-9
8011406
Dig Dis Sci. 1998 Jun;43(6):1226-9
9635612
Carcinogenesis. 2002 Nov;23(11):1927-31
12419842
Dig Dis Sci. 1998 Apr;43(4):854-62
9558044